JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4001
Kelly Services Class A
KELYA
$546M
| $1.14M | ﹤0.01% |
53,362
-44,531
| -45% | -$1.01M |
2013 Q2
44 quarters
|
|
|
PLYA
4002
DELISTED
Playa Hotels & Resorts
PLYA
| $1.14M | ﹤0.01% |
135,648
+87,909
| +184% | +$774K |
2024 Q1
1 quarter
|
|
|
CCRN
4003
DELISTED
Cross Country Healthcare
CCRN
| $1.13M | ﹤0.01% |
81,991
-54,747
| -40% | -$867K |
2013 Q2
44 quarters
|
|
4004
ProShares S&P SmallCap 600 Dividend Aristocrats ETF
SMDV
$661M
| $1.13M | ﹤0.01% |
18,264
-1,889
| -9% | -$118K |
2022 Q4
6 quarters
|
|
|
VRNA
4005
CALL
DELISTED
Verona Pharma
VRNA
| $1.13M | ﹤0.01% |
+78,400
| New | +$1.14M |
2024 Q2
0 quarters
|
|
|
FPI
4006
Farmland Partners
FPI
$490M
| $1.13M | ﹤0.01% |
98,322
-27,514
| -22% | -$303K |
2016 Q1
33 quarters
|
|
4007
Schwab International Dividend Equity ETF
SCHY
$2.51B
| $1.13M | ﹤0.01% |
47,988
-2,910
| -6% | -$70K |
2023 Q4
2 quarters
|
|
4008
iShares International Treasury Bond ETF
IGOV
$1.3B
| $1.13M | ﹤0.01% |
29,245
+164
| +0.6% | +$6.39K |
2022 Q3
7 quarters
|
|
4009
Ovid Therapeutics
OVID
$465M
| $1.13M | ﹤0.01% |
1,466,433
-111,628
| -7% | -$311K |
2017 Q4
26 quarters
|
|
4010
PUT
Teradyne
TER
$70.2B
| $1.13M | ﹤0.01% |
+7,600
| New | +$965K |
2024 Q2
0 quarters
|
|
4011
OptimizeRx
OPRX
$161M
| $1.13M | ﹤0.01% |
112,533
-26,515
| -19% | -$291K |
2018 Q4
22 quarters
|
|
4012
NovaGold Resources
NG
$2.87B
| $1.12M | ﹤0.01% |
324,964
-319,105
| -50% | -$1.06M |
2016 Q3
31 quarters
|
|
|
SPTN
4013
DELISTED
SpartanNash
SPTN
| $1.12M | ﹤0.01% |
59,767
-52,783
| -47% | -$1.03M |
2013 Q2
44 quarters
|
|
|
PSTL
4014
Postal Realty Trust
PSTL
$686M
| $1.12M | ﹤0.01% |
84,099
-32,879
| -28% | -$446K |
2019 Q4
18 quarters
|
|
4015
Brookdale Senior Living
BKD
$2.59B
| $1.12M | ﹤0.01% |
164,012
+13,179
| +9% | +$89.1K |
2013 Q2
44 quarters
|
|
4016
Simulations Plus
SLP
$374M
| $1.12M | ﹤0.01% |
22,994
-4,388
| -16% | -$207K |
2017 Q4
26 quarters
|
|
4017
Sinclair Inc
SBGI
$899M
| $1.12M | ﹤0.01% |
83,795
+70,919
| +551% | +$907K |
2013 Q2
44 quarters
|
|
|
APGE
4018
DELISTED
Apogee Therapeutics
APGE
| $1.12M | ﹤0.01% |
28,343
+4,010
| +16% | +$195K |
2023 Q3
3 quarters
|
|
|
XHYI
4019
DELISTED
BondBloxx USD High Yield Bond Industrial Sector ETF
XHYI
| $1.11M | ﹤0.01% |
+29,609
| New | +$1.11M |
2024 Q2
0 quarters
|
|
4020
PUT
Archer Daniels Midland
ADM
$38.8B
| $1.11M | ﹤0.01% |
+18,400
| New | +$1.13M |
2024 Q2
0 quarters
|
|
4021
AMC Entertainment Holdings
AMC
$2.47B
| $1.11M | ﹤0.01% |
222,407
-835,670
| -79% | -$3.36M |
2015 Q4
34 quarters
|
|
|
SUPV
4022
Grupo Supervielle
SUPV
$601M
| $1.11M | ﹤0.01% |
163,349
+83,913
| +106% | +$547K |
2023 Q4
2 quarters
|
|
4023
AdaptHealth
AHCO
$747M
| $1.11M | ﹤0.01% |
110,736
-228,082
| -67% | -$2.32M |
2020 Q2
16 quarters
|
|
4024
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.08B
| $1.11M | ﹤0.01% |
16,339
-32,894
| -67% | -$2.24M |
2023 Q4
2 quarters
|
|
4025
Karyopharm Therapeutics
KPTI
$18.2M
| $1.11M | ﹤0.01% |
85,057
-6,782
| -7% | -$112K |
2013 Q4
42 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.